On November 13, 2026, the Federal Trade Commission and attorneys general from 13 states filed suit in the U.S. District Court for the Southern District of New York to block Covetrus Inc. (and its private-equity owners Clayton, Dubilier & Rice and TPG) from acquiring MWI Veterinary Supply Inc. (MWI Animal Health) from Cencora Inc. for…
Continue reading ›Articles Posted in FTC Antitrust Highlights
On October 19, 2026, the Federal Trade Commission and a bipartisan coalition of 12 state attorneys general sued in the U.S. District Court for the Northern District of California to block Platinum Equity and its portfolio company PlayPower from acquiring BCI Burke, one of PlayPower’s closest competitors in commercial outdoor playground equipment. Just eight days…
Continue reading ›On August 14, 2026, after a seven-day trial, the U.S. District Court for the Southern District of New York granted the Federal Trade Commission’s request for a permanent injunction blocking Henkel AG & Co. KGaA’s proposed $725 million acquisition of the Liquid Nails brand from private-equity firm American Industrial Partners. The ruling permanently prevents the…
Continue reading ›On July 28, 2026, the Federal Trade Commission granted early termination of its Hart-Scott-Rodino review of IonQ Inc.’s approximately $1.8 billion acquisition of SkyWater Technology, Inc. The decision allowed the deal to close without conditions or a consent order. The outcome was not a unanimous determination that the transaction raised no competitive issues. It was…
Continue reading ›On June 18, 2026, the Federal Trade Commission issued a complaint and accepted a proposed consent order requiring Aurobindo Pharma Limited to divest four generic drug products as a condition of completing its approximately $250 million acquisition of Lannett Company, Inc. The action continues the agency’s longstanding approach in pharmaceutical mergers: when a transaction eliminates…
Continue reading ›On June 2, 2026, the Federal Trade Commission issued a complaint and accepted a proposed consent order requiring Ascension Health Alliance to divest seven ambulatory surgery centers as a condition of completing its approximately $3.9 billion acquisition of AmSurg LLC. The Commission later finalized the order on August 25, 2026, after a public comment period,…
Continue reading ›On March 16, 2026, Alcon, Inc. and LENSAR, Inc. mutually agreed to terminate their merger agreement after the Federal Trade Commission indicated it would seek to block the transaction. The proposed deal, announced in March 2025 and valued at approximately $356 million upfront (with potential milestones bringing the total to roughly $430 million), would have…
Continue reading ›On January 30, 2026, the Federal Trade Commission issued a complaint and accepted a proposed consent order requiring Sevita Health to divest 128 intermediate care facilities and related assets as a condition of completing its approximately $835 million acquisition of BrightSpring Health Services, Inc.’s ResCare Community Living business. The Commission finalized the order on June…
Continue reading ›On January 9, 2026, after a six-day trial, the U.S. District Court for the District of Columbia granted the Federal Trade Commission’s request for a preliminary injunction temporarily preventing Edwards Lifesciences Corp. from completing its proposed $945 million acquisition of JenaValve Technology, Inc. In response, Edwards announced that it would no longer pursue the acquisition.…
Continue reading ›On August 13, 2025, President Donald Trump issued an executive order revoking Executive Order 14036, the Biden-Harris administration’s 2021 directive aimed at promoting competition in the American economy. This move signals a shift in federal competition policy, drawing praise from business groups and criticism from consumer advocates. FTC Chairman Andrew N. Ferguson hailed the decision…
Continue reading ›





